We use cookies to make this site work. We'd also like to set optional cookies so we can understand how the site is used and improve it. We will not set optional cookies unless you accept them. You can change your choice at any time from the Cookie settings link in the footer.
Strictly necessary cookies
These cookies are required for the site to work. They store your cookie preferences and keep your session secure. They are exempt from consent under PECR Regulation 6(4) because they are essential to deliver the service you have requested.
Optional cookies
Optional cookies help us understand how the site is used and provide additional features such as analytics, accessibility tools and translation. We will only set them if you accept.
COVID-19 Antiviral and Antibody Treatments
Some people are now eligible to receive antiviral and antibody treatments for NHS patients at greater risk from severe COVID-19.
There are 2 ways in which you can receive antiviral treatments:
- as part of your standard care if you are at highest risk of severe COVID-19 and extremely vulnerable
- through a UK wide antiviral study called PANORAMIC available to COVID-19 positive patients over 50 or 18-49 with underlying health conditions
Antivirals will be used alongside the vaccine, which still remains our most effective tool.
Triniaethau gwrthfeirysol a gwrthgorff COVID-19
Mae rhai pobl bellach yn gymwys i dderbyn triniaethau gwrthfeirysol a gwrthgorff ar gyfer cleifion y GIG sydd mewn mwy o berygl o COVID-19 difrifol.
Mae dwy ffordd y gallwch dderbyn triniaethau gwrthfeirysol:
- fel rhan o'ch gofal safonol os ydych chi yn y risg uchaf o COVID-19 difrifol ac yn hynod fregus
- trwy astudiaeth wrthfeirysol ledled y DU o'r enw PANORAMIC sydd ar gael i gleifion cadarnhaol COVID-19 dros 50 neu 18-49 sydd â chyflyrau iechyd sylfaenol
Bydd cyffuriau gwrthfeirysol yn cael eu defnyddio ochr yn ochr â'r brechlyn, sef ein teclyn mwyaf effeithiol o hyd.
Published: Feb 27, 2023
